Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Kymera Therapeutics Announces Upsized Initial Public Offering
WATERTOWN, Mass., Aug. 20, 2020 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel sm…
Verastem Agrees to Sell Duvelisib Rights to Secura Bio
BOSTON - Aug. 10, 2020 - Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medici…
Ryvu Therapeutics Raises Over $36 Million
Krakow, Poland – July 22, 2020 – Ryvu Therapeutics [RVU], a clinical stage biopharmaceutical company developing novel small molecule therapies that ad…
Cobomarsen Received Orphan Drug Designation from the U.S. FDA for the Treatment of T-cell Lymphoma
BOULDER, Colo., July 23, 2020 - miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and dev…
BioTheryX Announces $35 Million Series D Financing
SAN DIEGO, CA, July 28, 2020 — BioTheryX, Inc., a clinical stage biotechnology company harnessing the power of protein modulation to treat difficult d…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
